Statistics for miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis
Total visits
| views | |
|---|---|
| miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis | 226 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| or-38-05-2717.pdf | 189 |
Top country views
| views | |
|---|---|
| United States | 175 |
| Germany | 12 |
| Sweden | 6 |
| Ukraine | 6 |
| Russia | 3 |
| Canada | 2 |
| United Kingdom | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 46 |
| Fairfield | 29 |
| Houston | 18 |
| Cambridge | 12 |
| Ann Arbor | 9 |
| Kiez | 9 |
| Jacksonville | 7 |
| White Plains | 6 |
| Kiev | 5 |
| Stockholm | 5 |
| San Francisco | 3 |
| Chicago | 2 |
| Gunzenhausen | 2 |
| Moscow | 2 |
| Toronto | 2 |
| Brooklyn | 1 |
| Kansas City | 1 |
| Lviv | 1 |
| Motala | 1 |
| Philadelphia | 1 |
| Plauen | 1 |
| Saint Petersburg | 1 |
| Scottsdale | 1 |
| Seattle | 1 |
| Seremban | 1 |